Identification of cryptic nuclear localization signals in the prion protein
暂无分享,去创建一个
Yaping Gu | Neena Singh | Neena Singh | Yaping Gu | Joerg Hinnerwisch | Rebecca Fredricks | Sudheera Kalepu | R. S. Mishra | Joerg Hinnerwisch | Rebecca Fredricks | Sudheera Kalepu | Ravi Shankar Mishra
[1] H. Budka,et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Ikonen,et al. Basolateral protein transport in streptolysin O-permeabilized MDCK cells , 1994, The Journal of cell biology.
[3] F. Cohen,et al. Prion diseases of humans and animals , 1996 .
[4] S. Ferrari,et al. Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein* , 1999, The Journal of Biological Chemistry.
[5] William D. Richardson,et al. A short amino acid sequence able to specify nuclear location , 1984, Cell.
[6] S. Prusiner,et al. Amyloid protein of Gerstmann‐Sträussler‐Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N‐terminal glycine at codon 58. , 1991, The EMBO journal.
[7] D. Harris,et al. A Mutant Prion Protein Displays an Aberrant Membrane Association When Expressed in Cultured Cells (*) , 1995, The Journal of Biological Chemistry.
[8] D. Dormont,et al. Search for a Nuclear Localization Signal in the Prion Protein , 1998, Molecular and Cellular Neuroscience.
[9] D. Harris,et al. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Harris,et al. Mutant and Infectious Prion Proteins Display Common Biochemical Properties in Cultured Cells (*) , 1996, The Journal of Biological Chemistry.
[11] S. Adam,et al. Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors , 1990, The Journal of cell biology.
[12] C. Weissmann,et al. Molecular Genetics of Transmissible Spongiform Encephalopathies* , 1999, The Journal of Biological Chemistry.
[13] Albert Taraboulos,et al. Proteasomes and ubiquitin are involved in the turnover of the wild‐type prion protein , 2001, The EMBO journal.
[14] A. Negro,et al. The Metabolism and Imaging in Live Cells of the Bovine Prion Protein in Its Native Form or Carrying Single Amino Acid Substitutions , 2001, Molecular and Cellular Neuroscience.
[15] B. Ghetti,et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Lee,et al. Internalization of mammalian fluorescent cellular prion protein and N‐terminal deletion mutants in living cells , 2001, Journal of neurochemistry.
[17] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[18] K Wüthrich,et al. NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.
[19] B. Ghetti,et al. Prion Protein Amyloidosis , 1996, Brain pathology.
[20] D. Harris,et al. Prion Diseases: What Is the Neurotoxic Molecule? , 2001, Neurobiology of Disease.
[21] Neena Singh,et al. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders. , 2003, Journal of Alzheimer's disease : JAD.
[22] B. Ghetti,et al. A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V* , 2001, The Journal of Biological Chemistry.
[23] P E Wright,et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] Shu G. Chen,et al. Prion Protein Aggregation Reverted by Low Temperature in Transfected Cells Carrying a Prion Protein Gene Mutation* , 1997, The Journal of Biological Chemistry.
[25] R. Sternglanz,et al. PNG1, a Yeast Gene Encoding a Highly Conserved Peptide:N-Glycanase , 2000, The Journal of cell biology.
[26] G. Dreyfuss,et al. Transport of Proteins and RNAs in and out of the Nucleus , 1999, Cell.
[27] R. Fletterick,et al. Predicted secondary structure and membrane topology of the scrapie prion protein. , 1987, Protein engineering.
[28] S. Lindquist,et al. De novo generation of a PrPSc-like conformation in living cells , 1999, Nature Cell Biology.
[29] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[30] M. Bachmann,et al. Kinetics of expression of prion protein in uninfected and scrapie‐infected N2a mouse neuroblastoma cells , 1993, Cell biochemistry and function.
[31] H. Kretzschmar,et al. Cellular Phenotyping of Secretory and Nuclear Prion Proteins Associated with Inherited Prion Diseases* , 2002, The Journal of Biological Chemistry.
[32] S. Lindquist,et al. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] Neena Singh,et al. Prion Peptide 106–126 Modulates the Aggregation of Cellular Prion Protein and Induces the Synthesis of Potentially Neurotoxic Transmembrane PrP* , 2002, The Journal of Biological Chemistry.
[34] Arunandan Kumar,et al. The Chaperone Protein BiP Binds to a Mutant Prion Protein and Mediates Its Degradation by the Proteasome* , 2000, The Journal of Biological Chemistry.
[35] Terrance T. Kummer,et al. Mutant Prion Proteins Are Partially Retained in the Endoplasmic Reticulum* , 2001, The Journal of Biological Chemistry.